Reasons to Retain Avanos Medical Stock in Your Portfolio for Now
AVNS' SNS momentum, Nexus Medical integration and AIP deal support growth, but tariff costs, margin pressure and PM&R weakness remain headwinds.
Avanos Medical (AVNS) Up 1.1% Since Last Earnings Report: Can It Continue?
Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock?
New Strong Sell Stocks for May 15th
AVNS, BKR and CAG have been added to the Zacks Rank #5 (Strong Sell) List on May 15th, 2026.
Deciphering Avanos Medical (AVNS) International Revenue Trends
Explore Avanos Medical's (AVNS) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
AVNS Gains After Posting Q1 Earnings Miss & Revenue Beat, Margins Down
Avanos Medical tops Q1 revenue estimates on strong SNS growth, but margin pressure and PM&R weakness weigh on earnings and profitability.
Avanos Medical (AVNS) Lags Q1 Earnings Estimates
Avanos Medical (AVNS) came out with quarterly earnings of $0.22 per share, missing the Zacks Consensus Estimate of $0.23 per share. This compares to earnings of $0.26 per share a year ago.
Reasons to Retain Avanos Medical Stock in Your Portfolio for Now
AVNS gains on strong SNS and PMR growth, M&A and cost actions, but tariff risks and segment headwinds may weigh on near-term performance.
Avanos Medical, Inc. (AVNS) Presents at The Citizens Life Sciences Conference 2026 Transcript
Avanos Medical, Inc. (AVNS) Presents at The Citizens Life Sciences Conference 2026 Transcript
Avanos Medical Stock Dips Despite Q4 Earnings Beat, Revenues Up Y/Y
AVNS shares plunge 10% even after a Q4 earnings and revenue beat, as margin pressure and tariff concerns weigh on investors.
Avanos Medical, Inc. (AVNS) Q4 2025 Earnings Call Transcript
Avanos Medical, Inc. (AVNS) Q4 2025 Earnings Call Transcript
Avanos Medical (AVNS) Q4 Earnings and Revenues Surpass Estimates
Avanos Medical (AVNS) came out with quarterly earnings of $0.29 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.43 per share a year ago.
Reasons to Retain Avanos Medical Stock in Your Portfolio Now
AVNS shows solid 3Q25 momentum from SNS and PMR growth, aided by M&A and cost cuts, even as tariffs and FX volatility linger.
